查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1391917

大肠桿菌菌株市场：按菌株类型、按应用、按致病性、按最终用户、按地区

Escherichia Coli Strain Market, By Strain Type, By Application, By Pathogenicity, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

大肠桿菌菌株市场预计将从 2023 年的 19.7 亿美元增加到 2030 年的 31.4 亿美元，2023 年至 2030 年的复合年增长率为 6.9%。

报告范围 报告详情
基准年 2022年 2023年市场规模 19.7亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.90% 2030年市场规模预测 31.4亿美元
图 1. 2023 年按地区分類的大肠桿菌菌株全球市场占有率(%)
大肠桿菌菌株市场-IMG1

大肠桿菌（Escherichia coli），俗称大肠桿菌，是一种因其多样化的特性和在研究中的广泛应用而具有重大科学意义的细菌菌株。这种细菌属于肠桿菌科，常见于人类和动物的胃肠道。值得注意的是，儘管大肠桿菌通常与食物中毒和感染疾病有关，但并非所有菌株都是有害的。事实上，许多细菌菌株都是有益的，并且在消化器官系统中发挥重要作用，有助于分解食物和吸收营养。然而，也有致病性大肠桿菌，可引起多种疾病，从轻微的胃肠道疾病到尿道感染、肺炎等严重，甚至危及生命的溶血性​​尿毒症综合症。大肠桿菌引起如此广泛的疾病的能力使其成为重要的公共卫生问题。大肠桿菌的多种特性及其在健康和疾病中的作用使其成为科学研究的重要模式生物。大肠桿菌在遗传学、生物化学和生物技术领域得到了广泛的研究，并对这些领域的理解做出了重大贡献。研究人员利用大肠桿菌研究细菌遗传学、研究代谢途径并开发新的生物技术应用。这项广泛的研究不仅加深了我们对大肠桿菌本身的了解，而且还为更广泛的生物过程提供了宝贵的见解。

市场动态：

生物技术研究、重组蛋白生产和药物开发预计将在预测期内推动全球大肠桿菌菌株市场的成长。此外，工业流程预计也将在预测期内促进全球大肠桿菌菌株市场的成长。生物製药生产、合成生物学、个人化医疗和生物修復预计将在预测期内为全球大肠桿菌市场提供成长机会。

然而，安全和生物安全问题、监管障碍、与其他微生物的竞争以及污染和交叉污染的风险预计将阻碍预测期内大肠桿菌菌株市场的成长。

本研究的主要特点

  • 本报告对全球大肠桿菌菌株进行了详细分析，并列出了以 2022 年为基准年的预测期（2023-2030）的市场规模和复合年增长率。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球大肠桿菌菌株市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、经营团队升级、市场扩张和行销策略做出资讯的决策。
  • 全球大肠桿菌菌株市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于全球大肠桿菌菌株市场分析的各种策略矩阵，促进了相关人员的决策。

目录

第1章调查目的和假设

  • 研究目标
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 生物技术研究预计将在预测期内推动市场成长
    • 抑制因素
  • 安全和生物安全担忧预计将阻碍预测期内的市场成长
    • 机会
  • 为精准医疗应用提供自订大肠桿菌菌株的个人化医疗预计将带来市场机会
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和合作

第4章大肠桿菌菌株市场－冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第5章大肠桿菌菌株市场，依菌株类型，2018-2030 年

  • 介绍
  • 共生菌株
  • 腹泻型
  • 肠外致病菌株
  • 泌尿系统株
  • 新生儿脑膜炎菌株
  • 其他的

第6章大肠桿菌菌株市场，依应用分类，2018-2030

  • 介绍
  • 诊断
  • 研究
  • 治疗
  • 重组蛋白生产
  • 品管微生物
  • 其他的

第7章大肠桿菌菌株市场，致病性，20218-2030

  • 介绍
  • 致病性大肠桿菌
  • 非致病性大肠桿菌

第8章大肠桿菌菌株市场，依最终使用者划分，2018-2030 年

  • 介绍
  • 研究机构
  • 诊断实验室
  • 製药和生物技术公司
  • 受託研究机构
  • 其他的

第9章大肠桿菌菌株市场，按地区，2018-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Novozymes A/S
    • QIAGEN NV
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript Biotech Corporation
    • Sanofi
    • Xiamen Innovax Biotech Co., Ltd

第11章章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6132

The escherichia coli strain market is expected to reach US$ 3.14 Bn by 2030 from US$ 1.97 Bn in 2023 and is expected to exhibit a compound annual growth rate (CAGR) of 6.9% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.97 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.90% 2030 Value Projection: US$ 3.14 Bn
Figure 1. Global Escherichia Coli Strain Market Share (%), By Region, 2023
Escherichia Coli Strain Market - IMG1

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market

Detailed Segmentation:

  • Escherichia Coli Strain Market Segmentation, By Strain Type:
    • Commensal strains
    • Diarrheal strains
    • Extraintestinal pathogenic strains
    • Uropathogenic strains
    • Neonatal meningitis strains
    • Others
  • Escherichia Coli Strain Market Segmentation, By Application:
    • Diagnostics
    • Research
    • Therapeutics
    • Production of recombinant proteins
    • Quality control organisms
    • Others
  • Escherichia Coli Strain Market Segmentation, By Pathogenicity:
    • Pathogenic E. coli
    • Non-pathogenic E. coli
  • Escherichia Coli Strain Market Segmentation, By End User:
    • Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Others
  • Escherichia Coli Strain Market Segmentation, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Escherichia Coili Strain Market:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Novozymes A/S
    • QIAGEN N.V.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript Biotech Corporation
    • Sanofi
    • Xiamen Innovax Biotech Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Strain Type
    • Market Snippet, By Application
    • Market Snippet, By Pathogenicity
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Biotechnology research is expected to drive the market growth over forecast period
    • Restraints
  • Safety and biosecurity concerns is expected to hinder the market growth over forecast period
    • Opportunities
  • Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Escherichia Coli Strain Market, By Strain Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Commensal strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diarrheal strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Extraintestinal pathogenic strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Uropathogenic strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Neonatal meningitis strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Escherichia Coli Strain Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Production of recombinant proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Quality control organisms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%) Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pathogenic E. coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Non-pathogenic E. coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Escherichia Coli Strain Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Escherichia Coli Strain Market, By Geography, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Merck KGaA
    • Novozymes A/S
    • QIAGEN N.V.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript Biotech Corporation
    • Sanofi
    • Xiamen Innovax Biotech Co., Ltd
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us